Author:
Ampadu Haggar Hilda,Esseku Yvonne,Dodoo Alexander N. O.
Reference49 articles.
1. World Health Assembly (1963) Clinical and pharmacological evaluation of drugs
2. Ampadu HH, Hoekman J, de Bruin ML, Pal SN, Olsson S, Sartori D et al (2016) Adverse drug reaction reporting in Africa and a comparison of individual case safety report characteristics between Africa and the rest of the world: analyses of spontaneous reports in VigiBase®. Drug Saf 39(4):335–345
3. Isah AO, Pal SN, Olsson S, Dodoo A, Bencheikh RS (2012) Specific features of medicines safety and pharmacovigilance in Africa. Ther Adv Drug Saf 3(1):25–34
4. Rovira J (2002) Pharmaceuticals, globalization and developing countries: recent developments and challenge. Pharm Policy Law 5:7–10
5. Pirmohamed M, Atuah KN, Dodoo AN, Winstanley P, Pirmohamed M, Atuah KN, Dodoo AN, Winstanley P (2007) Pharmacovigilance in developing countries. BMJ 335(7618):462
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献